Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 17/20 | 0.71 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4919839 | 1.00 | HRH3 (0.71) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4925845 | 0.88 | HRH3 (0.71) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4919952 | 0.88 | HRH3 (0.71) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4919893 | 0.88 | HRH3 (0.72) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4923581 | 0.88 | HRH3 (0.74) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4920896 | 0.84 | MEN1 (0.54) | HRH3SLC6A4MEN1KMT2ASLC6A2 | |
| SCHEMBL4920816 | 0.83 | SLC6A4 (1.00) | HRH3SLC6A4SLC6A2 | |
| SCHEMBL4921960 | 0.83 | SLC6A4 (1.00) | HRH3SLC6A4SLC6A2 | |
| SCHEMBL28285426 | 0.83 | HRH3 (0.88) | HRH3MEN1KMT2A | |
| SCHEMBL4910790 | 0.82 | HRH3 (0.58) | HRH3SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080139564-A1 | SUBSTITUTED PHENYL PROPYL AMINES AS HISTAMINE H3 RECEPTOR AND SEROTONIN TRANSPORTER MODULATORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139564-A1 | SUBSTITUTED PHENYL PROPYL AMINES AS HISTAMINE H3 RECEPTOR AND SEROTONIN TRANSPORTER MODULATORS | HRH3, SLC6A4, HNMT | HRH3 1/4885SLC6A4 2/4885MEN1 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.